%D8%AF%D9%8A%D8%B3%D9%88%D8%AC%D9%8A%D8%B3%D8%AA%D8%B1%D9%8A%D9%84DesogestrelDesogestrelDesogestrelDesogestrelDesogestreeliDesogestrel%E3%83%87%E3%82%BD%E3%82%B2%E3%82%B9%E3%83%88%E3%83%AC%E3%83%ABDezogestrelDesogestrelDesogestrelDesogestrelCerazetteDesogestrelQ415304%E5%8E%BB%E6%B0%A7%E5%AD%95%E7%83%AF
about
Acceptability of the NuvaRing Among StudentsComparative Trial in Hormone Withdrawal Associated SymptomsAn Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne TreatmentTherapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation SyndromeEffect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory BiomarkersAntepartum Etonogestrel Contraceptive Implant Insertion at TermHormonal Contraceptive Methods on Immunologic Changes in the Female Genital Tract (FGT) and SystemicallyPostoperative Desogestrel for Endometriosis Related PainStudy of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatmentHIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHICNew Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte DonorsDarunavir and Rilpivirine Interactions With Etonogestrel Contraceptive ImplantA Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral ContraceptivesAssessment of Desogestrel in Ondine SyndromeEvaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's HealthA Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy WomenThe Effect of Hormonal Contraceptives on Androgens and Glucose MetabolismPostpartum Etonogestrel Implant for AdolescentsContraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary SyndromeImmediate vs. Delayed Postpartum Etonogestrel ImplantComparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®Traditional Chinese Medicine, Western Medicine and Low-level Light Therapy(LLLT) for Primary Dysmenorrhea(PD)Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After PregnancyLabor and Delivery Implant Insertion: A Randomized Controlled TrialContraception in Women With Sickle Cell DiseaseA Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral TherapyNexplanon Application Post-AbortionEffects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local ImmunityEtonogestrel Implant and Postpartum InsertionEffectiveness of Prolonged Use of IUD/Implant for ContraceptionEfficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUBQuickstart of Nexplanon® at Medical AbortionEvaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ARTPerformance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and GoserelinA Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization CyclesPremenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and DrospirenoneIs Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?
P4844
Q61915399-65B82A11-B42E-49C9-9509-06F1ADBD7A9EQ61938118-BEFE8345-C529-4E78-AA4A-39D8D1A41D51Q61956290-8DFE1B73-382C-4E38-8A0C-8ACDDF41D7E9Q61957715-61155D65-1DC6-4DFC-AEFD-667295981B0AQ61967782-A83EDA0A-AF75-40DB-9D20-1A5409E30882Q62024905-4DBCC32C-22BC-4C67-8FC7-F2D6C46092CEQ62062415-9800C75B-EE18-464E-9501-B9CB216A55FEQ63317002-C488EDA3-A4CA-4F08-946F-0B56B8D17219Q63320890-0C9CF75F-2BAC-4999-870F-27E9E2CCC407Q63338757-4AAB740E-B46E-4F09-ACF3-8AD3202EF588Q63574937-7BCD01E9-8251-49E0-B41C-CDB1001FF34AQ63579263-819A5227-1127-44C2-AE46-FF68D6A67B1BQ63600044-F293A5E5-0BF1-44F1-A01E-D524BE456DF7Q63814124-B6C9DD81-B51E-40AD-BC89-F50EEC873E23Q63816205-5F4DCD67-095C-419F-95C3-75A3D6B79FFDQ63818057-821F3CC5-9BA0-40FC-A377-C8691608CABCQ63818766-155CA257-2240-4D8C-99D7-C1ACB1360735Q63836538-11E981BD-B56B-4658-8177-2732FA8920CAQ63837280-BD7B5251-B635-4F11-A685-681C2178A0D8Q63844276-5CCE1FF7-6947-4682-ACFA-FA86153D7904Q63844723-44FBC9A2-11EF-4B3F-984D-2EF41F698049Q64040835-F9632796-20DB-4A89-8005-68D335210947Q64121508-96AB6DBD-094E-4816-8F00-466AE728ADF5Q64150631-42843D3E-F05B-400F-892D-2761085F3F3EQ64186985-4A536DBA-74B4-463B-8089-3B5902591CF5Q64216845-FDB7DB72-9627-44EF-AF53-DAF3D1D94F6DQ64221684-112BC2CD-FC0A-4F63-B730-776F77974F36Q64392536-FA3F5C6F-A7C0-401D-9C8A-ACA4AC5B61F2Q64396022-5E0130C5-2C99-4BEE-8FCF-4F782567FE37Q64396158-5C40ABA3-6544-4092-B3BA-030D33AE3F2BQ64600408-F7A2B2A7-2EC4-4179-8C63-AC7C9B528D30Q64612214-30D2AA6B-56FA-48E8-BE8F-05D137B2C32AQ64622442-7B966463-93A0-4C7A-83CC-3D9DD980CD92Q64623231-98126405-96EA-45E6-9E84-E1B88B70231AQ64625831-C9D86599-1BDA-491A-8160-2E9D08D93073Q64636392-062188B5-1F5F-42DD-ACF4-BA1B3292384BQ64641846-CBD63EED-B330-4422-BABF-3CB4B46A4FC7Q64642534-D6575C75-6219-4A41-B027-29284E513724Q64647375-3748B481-9412-4AA8-9A32-9FD84250B0D3Q64647720-451878E9-A60F-459B-ACE0-5B3A407D1D4A
P4844
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Cerazette
@sv
Desogestreeli
@fi
Desogestrel
@de
Desogestrel
@es
Desogestrel
@it
Desogestrel
@nl
Desogestrel
@sh
Desogestrel
@sr
Desogestrel
@tr
Dezogestrel
@pl
type
label
Cerazette
@sv
Desogestreeli
@fi
Desogestrel
@de
Desogestrel
@es
Desogestrel
@it
Desogestrel
@nl
Desogestrel
@sh
Desogestrel
@sr
Desogestrel
@tr
Dezogestrel
@pl
altLabel
13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol
@cy
13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol
@en
Cerazette
@de
Cerazette
@en
Desogestrel
@en
Desogestrelum
@en
ORG-2969
@cy
ORG-2969
@en
prefLabel
Cerazette
@sv
Desogestreeli
@fi
Desogestrel
@de
Desogestrel
@es
Desogestrel
@it
Desogestrel
@nl
Desogestrel
@sh
Desogestrel
@sr
Desogestrel
@tr
Dezogestrel
@pl